Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2018 / Cilt: 24 - Sayı: 1

Indications for Human Albumin Infusion in a Neonatal Population: A Single Center Experience

Pages
47–51
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: The value of human albumin in the clinical setting continues to be controversial and well-designed guidelines for its use in NICUs should be established for the neonatal period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate the indications for human albumin infusion, the suitability of albumin infusion in neonatal intensive care units and neonatal outcomes after human albumin administration.
📊
Key Findings & Data:STUDY DESIGN: Infants who had hypoalbuminemia (albumin level <20 g/L) and were given albumin infusion at any time during hospitalization between December 2012 and December 2013 were included in the study.
💡
Conclusion & Impact:CONCLUSION: The value of human albumin in the clinical setting continues to be controversial and well-designed guidelines for its use in NICUs should be established for the neonatal period.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: To evaluate the indications for human albumin infusion, the suitability of albumin infusion in neonatal intensive care units and neonatal outcomes after human albumin administration. STUDY DESIGN: Infants who had hypoalbuminemia (albumin level <20 g/L) and were given albumin infusion at any time during hospitalization between December 2012 and December 2013 were included in the study. Mortality (group 1 (alive), group 2 (died during hospitalization)) and morbidities were recorded. Demographic properties were assessed retrospectively. RESULTS: 38 neonates required human albumin transfusion therapy 61 times during the study, 89.5% were premature birth. 9 (23.7%) of 38 patients underwent major surgery. Group I =survived and are currently alive (n=22, 58%), Group II=died during hospitalization (n=16, 42%). In the groups, aspartate aminotransferase, creatinine and albumin levels were significantly different before and after infusion. CONCLUSION: The value of human albumin in the clinical setting continues to be controversial and well-designed guidelines for its use in NICUs should be established for the neonatal period.

🔖

Cite This Article

DEĞIRMENCİOĞLU, H., SAY, B., OĞUZ, Ş. S. (2018). Indications for Human Albumin Infusion in a Neonatal Population: A Single Center Experience. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 24 - Sayı: 1, 47–51. https://ajindex.com/articles/162576

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Vanek V. The use of serum albumin as a prognostic or nutritional marker and the pros and cons of IV albumin therapy. Nutr Clin Pract 1998;13:110-122
  2. Takagi K, Tanaka H, Nishijima S, Masaoka N, Miyake Y, Sakata H, Satoh K. Fetal blood values by percutaneous umbilical blood sampling. Fetal Ther 1989;4(2-3):152- 160
  3. Margarson MP. Soni N. Serum albumin: touchstone or totem? Anaesthesia 1998;53(8):789-803
  4. Roberton NR. Use of albumin in neonatal resuscitation. Eur J Pediatr 1997;156(6):428-431
  5. Mirtallo JM, Caryer K, Schneider PJ, Ayers L, Fabri PJ. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin. Am J Hosp Pharm 1981; 38(12):1907-1910 6. Lay KS, Bancalari E, Malkus H, Baker R, Strauss J. Acute effects of albumin infusion on blood volume and renal function in premature infants with respiratory distress syndrome. J Pediatr 1980;97(4):619-623
  6. Greenough A, Morley CJ, Roberton NRC. Acute respiratory disease in the newborn. In: Roberton NRC, editor(s). Textbook of Neonatology. 2nd edition. London: Churchill Livingston 1992;385-504
  7. Greenough A, Roberton NRC. Acute respiratory disease in the newborn. In: Rennie JM, Roberton NRC, editor(s). Textbook of Neonatology. 3rd edition. Edinburgh: Churchill Livingston 1999;481-607
  8. Jardine LA, Jenkins-Manning S, Davies MW. Albumin infusion for low serum albumin in preterm newborn infants. Cochrane Database Syst Rev 2004;3:CD004208 8. Yamauchi A, Fukuhara Y, Yamamoto S, Yano F, Takenaka M, Imai E, et al. Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells. Am J Physiol 1992;263(2):397-404
  9. Reading RF, Ellis R, Fleetwood A. Plasma albumin and total protein in preterm babies from birth to eight weeks. Early Hum Dev 1990;22(2):81-87
  10. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2011;11:CD001208 11. Vincent JL, Sakr Y, Reinhart K. ‘Sepsis Occurrence in Acutely Ill Patients’ Investigators. Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 2005;9(6):745-754
  11. Kaminski MV, Williams SD. Review of the rapid normalization of serum albumin with modified total parenteral nutrition solutions. Crit Care Med 1990;18(3): 327-335
  12. Strobel JL, Cady SG, Borg TK, Terracio L, Baynes JW, Thorpe SR. Identification of fibrobl